In the dulaglutide head-to-head comparisons with exenatide twice daily and liraglutide, GI side effects were similar between groups [5,6] Exenatide bid & weekly, Liraglutide & Dulaglutide have themost weight reduction effect
Glucagon-like peptide-1: A multi-faceted anti-inflammatory agent
The SELECT trial, reported in the New England Journal of Medicine in 2023, followed 17,604 adults with obesity and pre-existing cardiovascular disease but no diabetes
Sometimes, over-the-counter bowel meds will be recommended by your doctor to also help manage this side effect
Book a free 10-minute intro call to see if Origin is right for your care needs
Image Credit: Love Employee / Shutterstock In a recent study published in the International Journal of Obesity , researchers assessed the effects of glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) agonists on weight and body composition in adults with overweight or obesity
